Literature DB >> 10457584

Immunologic privilege of the eye.

J W Streilein1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10457584     DOI： 10.1007/bf00810243

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  67 in total

1.  Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.

Authors:  G A Wilbanks; M Mammolenti; J W Streilein
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

2.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

Authors:  P B MEDAWAR
Journal:  Br J Exp Pathol       Date:  1948-02

Review 3.  Immunologically privileged sites.

Authors:  C F Barker; R E Billingham
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

4.  Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation.

Authors:  H J Kaplan; J W Streilein
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

5.  Do immunologically privileged sites require a functioning spleen?

Authors:  H J Kaplan; J W Streilein
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation.

Authors:  H J Kaplan; J W Streilein
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

7.  Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.

Authors:  Y Sano; S Okamoto; J W Streilein
Journal:  Curr Eye Res       Date:  1997-11       Impact factor: 2.424

8.  Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production.

Authors:  H Kawashima; S A Prasad; D S Gregerson
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

9.  Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation.

Authors:  R D Granstein; R Staszewski; T L Knisely; E Zeira; R Nazareno; M Latina; D M Albert
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

10.  Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas.

Authors:  J W Streilein; D Bradley; Y Sano; Y Sonoda
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-02       Impact factor: 4.799
View more
  15 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Antigenicity and immunogenicity of allogeneic retinal transplants.

Authors:  N G Anosova; B Illigens; F Boisgérault; E V Fedoseyeva; M J Young; G Benichou
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

4.  Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells.

Authors:  Jeong-Hyeon Sohn; Puran S Bora; Hye-Jung Suk; Hector Molina; Henry J Kaplan; Nalini S Bora
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

Review 5.  Fragile privileges: autoimmunity in brain and eye.

Authors:  Hartmut Wekerle; De-ming Sun
Journal:  Acta Pharmacol Sin       Date:  2010-09       Impact factor: 6.150

6.  [Intracameral application of corticosteroids for treating severe endothelial rejection after penetrating keratoplasty].

Authors:  F Birnbaum; P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

7.  Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.

Authors:  S Camelo; J Castellanos; M Lafage; M Lafon
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 8.  [Topical immunosuppressives after penetrating keratoplasty].

Authors:  F Birnbaum; A Reis; T Reinhard
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 9.  Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.

Authors:  Rachel R Caspi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Resting CD8 T cells recognize beta-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated.

Authors:  Scott W McPherson; Jing Yang; Chi-Chao Chan; Chunzhi Dou; Dale S Gregerson
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.